Page 54 - 《中国药房》2023年13期
P. 54

通心络胶囊对糖尿病肾病模型大鼠肾纤维化的干预作用
                                                                                                Δ


                *
          白 璐 ,沈士朋,王 倩,李 敏,郭 帅,刘茂东(河北医科大学第三医院肾内科,石家庄 050051)
          中图分类号  R965      文献标志码  A      文章编号  1001-0408(2023)13-1584-06
          DOI  10.6039/j.issn.1001-0408.2023.13.08

          摘   要  目的  探讨通心络胶囊对糖尿病肾病(DN)模型大鼠肾纤维化的干预作用及机制。方法  随机选取8只大鼠作为对照组
         (普通饲料),其余大鼠给予高糖高脂饲料饲养联合腹腔注射链脲佐菌素(35 mg/kg)建立DN模型。造模成功的大鼠随机分为模型
          组(纯化水)、厄贝沙坦组(阳性对照,14.12 mg/kg)、通心络胶囊组(0.3 g/kg),其中模型组12只,其余2组各11只。各组大鼠灌胃相
          应药物或水,每天给药1次,连续16周。末次给药后,检测大鼠空腹血糖、24 h尿蛋白(24 h UTP);观察大鼠肾皮质病理形态学变
          化;检测大鼠血清中纤溶酶原激活物(PA)、纤溶酶原激活剂抑制因子 1(PAI-1)水平;检测大鼠肾皮质中转化生长因子 β1 (TGF-
          β1 )、Ⅳ型胶原蛋白(COL-Ⅳ)、Wnt4、β-连环蛋白(β-catenin) mRNA表达水平;观察或检测大鼠肾皮质中TGF-β1、COL-Ⅳ、黏着斑
          激酶(FAK)、整合素连接激酶(ILK)、E-钙黏蛋白(E-cadherin)、PA、PAI-1、Wnt4、β-catenin蛋白沉积或表达水平。结果  与模型组比
          较,通心络胶囊组大鼠24 h UTP均显著降低(P<0.05);肾皮质病理损伤及纤维化程度均减轻;血清和肾皮质中PA表达水平均显
          著升高、PAI-1表达水平均显著降低(P<0.05);肾皮质中TGF-β1、COL-Ⅳ蛋白沉积及相应mRNA表达水平均显著减少或降低(P<
          0.05),ILK、FAK蛋白沉积均减少,E-cadherin蛋白沉积均增多,Wnt4、β-catenin 蛋白和mRNA的表达水平均显著降低(P<0.05)。
          结论  通心络胶囊能减轻DN模型大鼠肾组织病理损伤及肾纤维化程度,减少细胞外基质沉积;其机制可能与调节纤溶系统活性,
          降低ILK、FAK表达,抑制Wnt/β-catenin信号通路激活有关。
          关键词  糖尿病肾病;通心络胶囊;纤溶系统;肾纤维化;Wnt/β-catenin信号通路

          Intervention effect of Tongxinluo capsule on renal fibrosis in diabetic nephropathy rats
          BAI Lu,SHEN Shipeng,WANG Qian,LI Min,GUO Shuai,LIU Maodong(Dept.  of  Nephrology,  the  Third
          Hospital of Hebei Medical University, Shijiazhuang 050051, China)

          ABSTRACT    OBJECTIVE  To  explore  the  intervention  effect  and  related  mechanism  of  Tongxinluo  capsule  on  renal  fibrosis  in
          rats  with  diabetic  nephropathy (DN).  METHODS  Eight  rats  were  selected  as  control  group (ordinary  feed),  the  remaining  rats
          were given high-glucose and high-fat diet combined with ip injection of streptozotocin (35 mg/kg) to induce DN model. Model rats
          were  randomly  divided  into  model  group (purified  water),  irbesartan  group (positive  control,  14.12  mg/kg)  and  Tongxinluo
          capsule  group (0.3  g/kg),  including  12  rats  in  the  model  group  and  11  rats  for  each  of  the  other  two  groups.  All  groups  were
          given  relevant  medicine  or  water  intragastrically,  once  a  day,  for  16  consecutive  weeks. After  the  last  medication,  fasting  blood
          glucose  and  24  h  urinary  total  protein (24  h  UTP)  were  detected.  Pathological  changes  in  renal  cortex  of  rats  in  each  group  were
          observed.  Serum  levels  of  tissue-type  plasminogen  activator (PA)  and  plasminogen  activator  inhibitor  1 (PAI-1)  were  measured.
          mRNA expressions of transforming growth factor-β1 (TGF-β1 ), type Ⅳ collagen(COL-Ⅳ), Wnt4 and β-catenin in renal cortex of
          rats  were  detected.  The  protein  depositions  or  expressions  of  TGF- β1,  COL- Ⅳ ,  focal  adhesion  kinase (FAK),  integrin-linked
          kinase (ILK),  E-cadherin,  PA,  PAI-1,  Wnt4  and  β -catenin  in  renal  cortex  of  rats  were  observed  or  determined.  RESULTS
          Compared with model group, 24 h UTP of rats in Tongxinluo capsule group were all significantly reduced (P<0.05); pathological
          damage  and  fibrosis  of  renal  cortex  were  relieved;  the  expression  of  PA  in  serum  and  renal  cortex  was  significantly  increased,
          while  PAI-1  level  was  significantly  reduced (P<0.05);  the  depositions  of  COL-Ⅳ  and TGF-β1  in  renal  cortex  were  all  reduced,
          and  corresponding  mRNA  expression  was  decreased  significantly (P<0.05);  the  depositions  of  ILK  and  FAK  were  decreased,
          while the deposition of E-cadherin was increased; protein and mRNA expressions of Wnt4 and β-catenin were significantly reduced
         (P<0.05).  CONCLUSIONS  Tongxinluo  capsule  can  relieve  pathological  damage  to  renal  tissue  and  renal  fibrosis  of  DN  model
          rats,  and  reduce  extracellular  matrix  deposition.  The  mechanism  may  be  related  to  regulation  of  fibrinolytic  system  activity,  the
          decrease of ILK and FAK expression, and inhibition of Wnt/β-catenin signaling pathway.
          KEYWORDS     diabetic nephropathy; Tongxinluo capsule; fibrinolytic system; renal fibrosis; Wnt/β-catenin signaling pathway


                                                                  糖尿病肾病(diabetic nephropathy,DN)是糖尿病常
              Δ 基金项目 河北省中医药管理局科研计划项目(No.2019131,No.
                                                              见而严重的微血管病变之一,以持续蛋白尿及进行性肾
          2022408)
                                                              功能恶化为临床表现,主要的病理特征为肾小球基底膜
             *第一作者 副主任医师,博士。研究方向:肾脏病的中西医结合
          治疗。E-mail:bailu2011@126.com                         弥漫性增厚、系膜基质增生、Kimmelstiel-Wilson 结节形


          · 1584 ·    China Pharmacy  2023 Vol. 34  No. 13                            中国药房  2023年第34卷第13期
   49   50   51   52   53   54   55   56   57   58   59